Please login to the form below

Not currently logged in


This page shows the latest Ofev news and features for those working in and with pharma, biotech and healthcare.

With Spiriva under pressure, Boehringer moves to bolster pipeline

With Spiriva under pressure, Boehringer moves to bolster pipeline

despite solid growth for diabetes drug Jardiance (empagliflozin)   and idiopathic pulmonary fibrosis (IPF) treatment Ofev (nintedanib). ... slack. Last year Jardiance grew 45% to 1.5bn, thanks in part to a new cardiovascular claim on the label, while

Latest news

More from news
Approximately 6 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...